A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
An open study of patients treated with deep brain stimulation for refractory obsessive-compulsive disorder confirms the treatment’s effectiveness and safety in a clinical setting, researchers concluded in a study published online.
A genome-wide association study has identified several human genome regions related to anxiety risk, and provides the first significant genome-wide findings regarding anxiety in people of African ancestry.
Despite popular belief that omega-3 fatty acids can combat anxiety and depression, omega-3 supplements likely offer little or no actual effect on symptoms, researchers reported online in The British Journal of Psychiatry.
People with mood or anxiety disorders demonstrate shared abnormalities in brain regions involved in emotional and cognitive control, according to a meta-analysis of brain scans published online in JAMA Psychiatry.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.